Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-108116
Filing Date
2025-08-13
Accepted
2025-08-13 16:47:24
Documents
70
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ck0001774857-20250630.htm   iXBRL 10-Q 2609107
2 EX-10.1 ck0001774857-ex10_1.htm EX-10.1 223022
3 EX-10.2 ck0001774857-ex10_2.htm EX-10.2 117547
4 EX-10.3 ck0001774857-ex10_3.htm EX-10.3 75276
5 EX-31.1 ck0001774857-ex31_1.htm EX-31.1 17550
6 EX-31.2 ck0001774857-ex31_2.htm EX-31.2 17526
7 EX-32.1 ck0001774857-ex32_1.htm EX-32.1 12468
8 EX-32.2 ck0001774857-ex32_2.htm EX-32.2 12225
9 GRAPHIC img180519618_0.jpg GRAPHIC 957480
10 GRAPHIC img180519618_1.jpg GRAPHIC 949561
11 GRAPHIC img180519618_2.jpg GRAPHIC 678912
12 GRAPHIC img180519618_3.jpg GRAPHIC 1188004
13 GRAPHIC img180519618_4.jpg GRAPHIC 985921
  Complete submission text file 0000950170-25-108116.txt   18315964

Data Files

Seq Description Document Type Size
14 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ck0001774857-20250630.xsd EX-101.SCH 861108
73 EXTRACTED XBRL INSTANCE DOCUMENT ck0001774857-20250630_htm.xml XML 1145659
Mailing Address 4370 LA JOLLA VILLAGE DRIVE SUITE 1050 SAN DIEGO CA 92122
Business Address 4370 LA JOLLA VILLAGE DRIVE SUITE 1050 SAN DIEGO CA 92122 (858) 225-7696
Aardvark Therapeutics, Inc. (Filer) CIK: 0001774857 (see all company filings)

EIN.: 821606367 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42513 | Film No.: 251212445
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)